==== Front Cancer Med Cancer Med 10.1002/(ISSN)2045-7634 CAM4 Cancer Medicine 2045-7634 John Wiley and Sons Inc. Hoboken 37132165 10.1002/cam4.6025 CAM46025 CAM4-2022-12-5493.R2 Research Article RESEARCH ARTICLES Cancer Prevention Global, regional, and national burden of oral cancer and its attributable risk factors from 1990 to 2019 Sun et al. Sun Rongyin https://orcid.org/0000-0001-7237-1853 1 Dou Weijie 2 Liu Weiliang 3 Li Jin 4 Han Xiangxiang 1 Li Shunhang 1 Wu Xueqian 5 Wang Fei 5 Xu Xin 1 xuxin@wfmc.edu.cn Li Jing 5 lijing@wfmc.edu.cn 1 School of Stomatology Weifang Medical University Weifang People's Republic of China 2 School of Health Care Security First Medical University & Shandong Academy of Medical Sciences Jinan People's Republic of China 3 Institute of Health Education and Promotion, Shandong Center for Disease Control and Prevention Jinan People's Republic of China 4 Weifang People's Hospital Weifang People's Republic of China 5 School of Public Health Weifang Medical University Weifang People's Republic of China * Correspondence Xin Xu, School of Stomatology, Weifang Medical University, No. 7166 Baotong West Street, Weifang 261053, Shandong Province, People's Republic of China. Email: xuxin@wfmc.edu.cn Jing Li, School of Public Health, Weifang Medical University, No. 7166 Baotong West Street, Weifang 261053, Shandong Province, People's Republic of China. Email: lijing@wfmc.edu.cn 02 5 2023 6 2023 12 12 10.1002/cam4.v12.12 1381113820 06 4 2023 12 12 2022 21 4 2023 © 2023 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/ This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. Abstract Background This study aims to provide a theoretical basis for the prevention of oral cancer by analyzing the epidemiological trends of oral cancer. Materials and Methods The data on oral cancer from 1990 to 2019 were extracted from the Global Burden of Disease 2019 database. The incidence, mortality, disability‐adjusted life years (DALYs), and age‐standardized rate as well as attributable risk factors of oral cancer were used for the analysis. Estimated annual percentage change (EAPC) was calculated to describe the changes in age‐standardized incidence rate (ASIR), age‐standardized mortality rate (ASMR), and age‐standardized DALYs rate (ASDR). Results The global ASIR of oral cancer showed an increasing trend from 1990 to 2019. ASIR in high SDI regions showed a decreasing trend during the studied period, with high SDI regions having the lowest ASMR in 2019. In 2019, the highest ASIR, ASMR, and ASDR were detected in South Asia. At the national level, Pakistan had the highest ASMR and ASDR in 2019. The increasing disease burden was observed in younger populations aged below 45 during the studied period. Smoking and alcohol use still exerted profound impacts on the oral cancer burden, with South Asia having the greatest increase in the percentage of deaths due to oral cancer attributable to chewing tobacco from 1990 to 2019. Conclusion In conclusion, there is a large variability in the temporal and spatial burden of oral cancer, and it is essential for priority countries to take targeted intervention policies and measures to reduce the disease burden of oral cancer. In addition, the oral cancer burden caused by attributable risk factors should also receive close attention. burden of disease disability‐adjusted life years incidence mortality oral cancer risk factors Shandong traditional Chinese medicine science and technology projectM‐2022235 Weifang Medical Science and technology development plan project2021YX047 High‐quality professional degree teaching case base project of Shandong ProvinceSDYAL2022149 Student Innovation and Entrepreneurship Training Plan of Weifang Medical UniversityX2022242 Public Domestic Visiting Program of Weifang Medical University20237‐10 source-schema-version-number2.0 cover-dateJune 2023 details-of-publishers-convertorConverter:WILEY_ML3GV2_TO_JATSPMC version:6.3.0 mode:remove_FC converted:03.07.2023 Sun R , Dou W , Liu W , et al. Global, regional, and national burden of oral cancer and its attributable risk factors from 1990 to 2019. Cancer Med. 2023;12 :13811‐13820. doi:10.1002/cam4.6025 Rongyin Sun and Weijie Dou contributed equally to this work. ==== Body pmc1 INTRODUCTION As one of the most common malignancies occurring in the head and neck, the global epidemiological trends of oral cancer are changing significantly. 1 The global estimated number of new cases of oral cancer increased from 354,864 reported by GLOBOCAN 2018 to 377,173 reported by GLOBOCAN 2020, and the number of new deaths remained stable at approximately 177,000. 2 , 3 While the clinical symptoms and treatments of oral cancer can reduce the quality of life of patients and cause serious economic and psychological burdens. 4 Noticeable geographic heterogeneity exists in the disease burden of oral cancer. A high prevalence of oral cancer has been observed in South and Southeast Asia. 5 It has been reported that India accounted for about one‐third of the total global burden of oral cancer. 6 The economic level also has a substantial impact on the disease burden of oral cancer. Compared with developed countries, the burden in developing countries are more serious. 7 Low socioeconomic status can add to the incidence risk of oral cancer, similar to the impact of lifestyle risk factors. 8 However, the prognosis of oral cancer in developed countries is also unsatisfactory, with a five‐year survival rate in the United States being only 65%. 9 Oral cancer is harmful to both society and individuals, thus it is necessary to conduct a comprehensive and systematic study on the burden of this disease. Although there have been previous studies on the disease burden of oral cancer, 10 , 11 few analyses have been performed on the changing trends of attributable risk factors of oral cancer. Investigation of the above trends can help lay a foundation for the formulation of the primary prevention policies for oral cancer. 12 Thus, the purpose of this study is to analyze the temporal and spatial burden of oral cancer and further evaluate the impact of attributable risk factors on oral cancer, which may facilitate the adoption of targeted measures by local governments to prevent oral cancer. 2 MATERIALS AND METHODS 2.1 Study data The data included in this study were extracted from the Global Burden of Disease (GBD) 2019 database, which quantified the health loss caused by 369 diseases, injuries and 87 risk factors in 204 countries and territories. 13 , 14 All data were obtained through an online query tool at the GBD website (http://ghdx.healthdata.org/gbd‐results‐tool). Geographically, 21 GBD regions were divided in the GBD study. The socio‐demographic index (SDI) is a comprehensive index composed of income per capita, average educational attainment and fertility rate. 15 The SDI value ranges from 0 to 1, with lower values indicating lower theoretical level of development related to health outcomes. The countries are divided into five levels (low, low‐middle, middle, high‐middle, and high SDI) based on the SDI values. International Classification of Diseases (ICD) is used in the GBD study to classify the studied diseases, and the ICD‐10 code for oral cancer included in this study was C00–C08. Oropharyngeal and nasopharyngeal cancers were excluded. Observed indicators included the incidence, mortality and disability‐adjusted life years (DALYs) at the global, regional and national levels from 1990 to 2019, as well as their related age‐standardized rate (ASR). The 95% uncertainty interval (95% UI) was the estimate due to measurement errors and biases. 16 Annual data on attributable risk factors for deaths and DALYs of oral cancer were also extracted, including smoking, alcohol use, and use of chewing tobacco. The age groups selected were 0–14, 15–19 … 80–84, 85 years and older. 2.2 Statistical analysis The formula for the calculation of the ASR (per 100,000 people) was presented as ASR = ∑i=1Aaiwi∑i=1Awi×100,000, which could indicate the differences between groups with varying age compositions. 17 The estimated annual percentage change (EAPC) was calculated to reflect and measure the changing trends of ASR within a specific time period. 18 Under the linear model, a regression line is consistent with the natural logarithm of ASR, that is, y = α + βx + ϵ, with y representing ln(ASR), x referring to calendar year, and ϵ being the error term. EAPC was calculated as 100 × [exp (β)–1], and its 95% confidence interval (95% CI) could be obtained from the linear regression model. 19 If both EAPC and the lower limit of its 95% CI were greater than 0, the trend of ASR variation would be regarded as upward; on the contrary, if both EAPC and its upper limit 95% CI were lower than 0, the trend of ASR variation would be considered downward. All statistical analyses and data visualization were conducted using the R software (version 4.2.1). 3 RESULTS 3.1 Incidence of oral cancer At the global level, the age‐standardized incidence rate (ASIR) of oral cancer increased slightly from 4.28/100,000 to 4.52/100,000 from 1990 to 2019. Compared with that in 1990, the global ASIR of males decreased and of females increased in 2019. The incident cases of oral cancer in the world and all GBD regions has increased in different proportions during the period (Table 1). TABLE 1 The incident cases and ASIR of oral cancer in 1990 and 2019. Location 1990 2019 Incident cases (×103) ASIR (1/105) Incident cases (×103) ASIR (1/105) Global 175.63 (167.52–184.91) 4.28 (4.07–4.51) 373.10 (340.88–403.87) 4.52 (4.13–4.89) Sex Male 120.66 (112.73–129.49) 6.24 (5.84–6.70) 243.19 (218.65–268.26) 6.16 (5.55–6.19) Female 54.97 (51.32–58.50) 2.54 (2.37–2.70) 129.91 (117.07–142.96) 3.01 (2.71–3.31) SDI level Low SDI 12.33 (10.40–14.36) 4.75 (3.99–5.54) 30.84 (27.23–34.74) 5.36 (4.76–6.00) Low‐middle SDI 38.07 (33.58–43.11) 5.88 (5.15–6.68) 95.60 (83.27–10.83) 6.65 (5.81–7.52) Middle SDI 31.47 (29.34–33.56) 2.87 (2.68–3.06) 94.42 (82.94–105.84) 3.72 (3.28–4.16) High‐middle SDI 38.60 (37.41–39.79) 3.55 (3.44–3.66) 71.61 (64.77–78.12) 3.56 (3.22–3.88) High SDI 55.08 (53.52–56.28) 5.50 (5.35–5.61) 80.46 (72.63–88.74) 4.71 (4.26–5.20) Region Andean Latin America 0.31 (0.27–0.35) 1.43 (1.26–1.61) 0.87 (0.70–1.05) 1.53 (1.24–1.86) Australasia 1.53 (1.46–1.60) 6.67 (6.36–6.98) 1.84 (1.50–2.25) 4.05 (3.27–4.95) Caribbean 1.09 (1.02–1.16) 4.14 (3.88–4.43) 2.10 (1.79–2.45) 4.05 (3.45–4.73) Central Asia 1.35 (1.26–1.52) 2.74 (2.54–3.11) 2.41 (2.18–2.67) 3.06 (2.78–3.40) Central Europe 6.96 (6.77–7.14) 4.79 (4.66–4.92) 10.34 (8.98–11.72) 5.35 (4.66–6.07) Central Latin America 1.66 (1.60–1.70) 1.94 (1.86–2.00) 4.25 (3.63–4.93) 1.80 (1.54–2.09) Central Sub‐Saharan Africa 0.64 (0.49–0.81) 2.63 (1.97–3.30) 1.52 (1.15–1.93) 2.64 (1.98–3.34) East Asia 13.86 (12.34–15.53) 1.50 (1.34–1.67) 52.04 (44.27–61.05) 2.50 (2.13–2.92) Eastern Europe 9.20 (8.68–9.79) 3.29 (3.11–3.51) 12.96 (11.61–14.51) 3.98 (3.56–4.46) Eastern Sub‐Saharan Africa 2.47 (2.09–2.92) 2.92 (2.46–3.45) 6.12 (5.13–7.09) 3.28 (2.77–3.74) High‐income Asia Pacific 3.57 (3.44–3.67) 1.78 (1.71–1.84) 8.48 (7.21–9.69) 2.07 (1.79–2.36) High‐income North America 2.34 (2.27–2.40) 6.98 (6.78–7.14) 33.20 (28.79–38.39) 5.60 (4.85–6.49) North Africa and Middle East 2.42 (2.03–2.79) 1.33 (1.12–1.54) 6.65 (5.81–7.69) 1.46 (1.28–1.68) Oceania 0.10 (0.08–0.13) 2.87 (2.25–3.71) 0.25 (0.19–0.34) 3.17 (2.49–4.15) South Asia 54.22 (47.97–61.09) 8.82 (7.71–10.01) 143.20 (120.85–166.17) 9.65 (8.17–11.15) Southeast Asia 11.13 (10.02–12.07) 4.13 (3.70–4.49) 28.95 (24.16–34.65) 4.70 (3.94–5.65) Southern Latin America 1.29 (1.23–1.35) 2.78 (2.66–2.91) 2.14 (1.68–2.68) 2.62 (2.06–3.30) Southern Sub‐Saharan Africa 1.18 (1.05–1.39) 4.01 (3.54–4.78) 2.21 (2.01–2.44) 3.72 (3.39–4.10) Tropical Latin America 3.95 (3.81–4.08) 4.11 (3.94–4.25) 9.74 (9.16–10.24) 3.94 (3.71–4.15) Western Europe 34.03 (32.99–34.96) 6.48 (6.29–6.66) 40.62 (35.16–46.78) 5.17 (4.46–5.96) Western Sub‐Saharan Africa 1.24 (1.05–1.42) 1.34 (1.15–1.53) 3.21 (2.71–3.75) 1.60 (1.38–1.84) Note: Incident cases (95% uncertainty interval). Abbreviations: ASIR: age‐standardized incidence rate (95% uncertainty interval). The highest ASIR was observed in South Asia (9.65/100,000) in 2019, which was approximately twice as that in North America, where the economic status is higher (Figure 1A). The incident cases of oral cancer in five SDI regions showed an increasing trend from 1990 to 2019 (Figure 1B), and only the ASIR in high SDI regions showed a decreasing trend during the studied period. Low SDI regions (6.65/100,000) had the highest ASIR of oral cancer in 2019 (Figure 1C). At the national level, Palau (29.85/100,000) had the highest ASIR in 2019, followed by Pakistan (Figure 1D). Changes in incident cases in 204 countries and territories between 1990 and 2019 are presented in Figure 1E. Global incident cases and ASIR in 2019 are exhibited by sex and age groups in Figure 1F. The highest incident cases of oral cancer in males and females were in the 60‐ to 64‐year‐old and 65‐ to 69‐year‐old groups, respectively. Compared with those in 1990, the global incident cases and ASIR in individuals aged below 45 increased in 2019 (Table S3). FIGURE 1 The incidence of oral cancer. (A) the trend of ASIR by SDI from 1990 to 2019 at the global and regional levels; (B,C) the trends of incident cases and ASIR in five SDI regions from 1990 to 2019; (D) the ASIR in 204 countries and territories in 2019; (E) The change in incident cases of oral cancer over the past 30 years; (F) global incident cases and ASIR of oral cancer by age and sex in 2019. ASIR, age‐standardized incidence rate. SDI, socio‐demographic index. 3.2 Mortality of oral cancer Globally, the deaths caused by oral cancer in 2019 (199.40 × 103) were more than twice as many as those in 1990 (96.63 × 103). Deaths due to oral cancer in all GBD regions also showed increasing trends during the studied period. However, the global age‐standardized mortality rate (ASMR) in 1990 and 2019 remained stable. Compared with that in 1990, the global ASMR of males and females in 2019 decreased and increased, respectively (Table S1). South Asia (6.36/100,000) had the highest ASMR of oral cancer in 2019, followed by Central Europe (Figure 2A). Deaths due to oral cancer in five SDI regions showed increasing trends from 1990 to 2019 (Figure 2B), and the lowest ASMR of oral cancer was found in high SDI regions (1.59/100,000) in 2019 (Figure 2C). At the national level, ASMR in almost a quarter of the countries and territories exceeded the global average level in 2019, with Pakistan (14.72/100,000) having the highest ASMR, followed by Palau (Figure 2D). Variations in the number of deaths due to oral cancer in the 204 countries and territories from 1990 to 2019 are presented in Figure 2E. In 2019, more deaths and a higher ASMR were found in males than females in most age groups (Figure 2F). Compared with those in 1990, the global deaths and ASMR in individuals aged below 45 remained stable or increased in 2019 (Table S4). FIGURE 2 The mortality of oral cancer. (A) the trend of ASMR by SDI from 1990 to 2019 at the global and regional levels; (B,C) the trends of deaths and ASMR in five SDI regions from 1990 to 2019; (D) the ASMR in 204 countries and territories in 2019; (E) The change in deaths of oral cancer over the past 30 years; (F) global deaths and ASMR of oral cancer by age and sex in 2019. ASMR, age‐standardized mortality rate. SDI, socio‐demographic index. 3.3 DALYs of oral cancer At the global level, DALYs of oral cancer increased by 92.89% (95% UI: 67.78%–117.64%) from 1990 to 2019, and increasing trends of the DALYs were observed in all GBD regions except Western Europe. The age‐standardized DALYs rate (ASDR) of oral cancer decreased from 67.01/100,000 in 1990 to 66.05/100,000 in 2019. Compared with that in 1990, the global ASDR of males decreased and of females increased in 2019 (Table S2). The highest ASDR was observed in South Asia (173.17/100,000) in 2019, nearly five times that in North America, where the economic status is higher (Figure 3A). The DALYs of oral cancer in five SDI regions showed increasing trends from 1990 to 2019 (Figure 3B). The ASDR in high‐middle SDI and high SDI regions decreased during the studied period, and high SDI regions (40.83/100,000) had the lowest ASDR in 2019 (Figure 3C). At the national level, Pakistan (421.87/100,000) had the highest ASDR in 2019, followed by Palau (Figure 3D). Variations in oral cancer DALYs in the 204 countries and territories during the studied period are displayed in Figure 3E. The ASDR in males peaked at the age of 65–69 years, while the ASDR in females increased with age (Figure 3F). Compared with those in 1990, the global DALYs and ASDR in individuals aged below 45 also increased in 2019 (Table S5). FIGURE 3 The DALYs of oral cancer. (A) the trend of ASDR by SDI from 1990 to 2019 at the global and regional levels; (B,C) the trends of DALYs and ASDR in five SDI regions from 1990 to 2019; (D) the ASDR in 204 countries and territories in 2019; (E) The change in DALYs of oral cancer over the past 30 years; (F) global DALYs and ASDR of oral cancer by age and sex in 2019. ASDR, age‐standardized DALYs rate. SDI: socio‐demographic index. 3.4 EAPC in incidence, mortality, and DALYs From 1990 to 2019, the global EAPC of oral cancer was 0.14% in ASIR (Figure S1A), −0.05% in ASMR (Figure S2A), and − 0.12% in ASDR (Figure S3A). The highest EAPCs in ASIR, ASMR and ASDR were found in East Asia, indicating that this area had the greatest increase in ASR during the studied period. Significant differences were observed in the EAPC of ASIR, ASMR and ASDR in the 204 countries and territories (Figures S1B–S3B), with Cabo Verde having the highest EAPC of ASIR, ASMR, and ASDR, at 5.11%, 4.64%, and 4.75%, respectively; the lowest EAPC was observed in Mongolia. 3.5 Attributable risk factors At the global level, the percentage of oral cancer deaths attributable to both smoking and alcohol use showed decreasing trends from 1990 to 2019, and the percentage of oral cancer deaths attributable to the use of chewing tobacco increased from 15.95% in 1990 to 18.70% in 2019 (Figure S4A,B). Compared with that in 1990, except for East Asia and Eastern Europe, the percentage of oral cancer deaths attributable to smoking in all GBD regions and SDI regions showed downward trends in 2019. Through the studied period, the percentage of oral cancer deaths attributable to alcohol use decreased in high‐middle and high SDI regions. The greatest increase in the percentage of oral cancer deaths attributable to the use of chewing tobacco was found in South Asia from 1990 to 2019. The global DALYs of oral cancer was also affected by the above risk factors in 2019, with 30.08% attributable to smoking, 31.36% attributable to alcohol use and 18.66% attributable to the use of chewing tobacco. In addition, during the studied period, East Asia and Southeast Asia have witnessed the greatest increase in the percentage of oral cancer DALYs attributable to smoking and alcohol use, respectively. In 2019, the highest percentage of oral cancer DALYs attributable to the use of chewing tobacco was observed in South Asia. 4 DISCUSSION The present study revealed that the disease burden of oral cancer has changed substantially from 1990 to 2019. From a global perspective, the incident cases and ASIR of oral cancer showed an upward trend during the studied period. The development of screening technologies such as salivary biomarkers has contributed to the early detection of oral cancer, 20 , 21 so that the accurate identification of patients who have not been diagnosed with oral cancer before may explain the above results. On the other hand, the global ASMR and ASDR of oral cancer were stable or showed decreasing trends, which might be related to the development of multidisciplinary treatment strategies and the application of adjuvant therapies, which can significantly improve the prognosis of oral cancer. 22 , 23 At the regional and national levels, serious disease burden of oral cancer was observed in Asia. South Asia had the largest number of incident cases, deaths and DALYs as well as the highest corresponding ASR in 2019, and the increasing burden of oral cancer in India played a key role in this during the studied period. A study using statistics from the international agency for research on cancer (IARC) has also demonstrated that India and Pakistan had a high burden of oral cancer. 24 It can be found that tobacco (including smoking and smokeless) and alcohol use are significant attributable risk factors for oral cancer in Asia, 4 with South Asian countries maintaining a high tobacco consumption rate. In addition to smoking, smokeless tobacco (SLT) also has oral carcinogenicity. 25 The main burden of SLT is concentrated in South Asian countries, with India being one of the countries bearing the dual burden of smoking and SLT. 26 Chewing tobacco is a form of SLT. The present study indicated that the use of chewing tobacco substantially contributed to the deaths and DALYs due to oral cancer in South Asia. A previous study reported that 83.29% of global chewing tobacco users were observed in South Asia in 2019, and the prevalence rate has remained high. 27 It has also been reported that smoking and alcohol consumption were significantly associated with higher susceptibility to oral cancer in people in East Asia, 28 with smoking and alcohol consumption acting independently and synergistically on increasing the incidence risk of oral cancer. 29 Involuntary smoking may also be strongly associated with oral cancer in East Asian individuals. 30 In addition to the above attributable risk factors, areca nut is another well‐known risk factor leading to oral cancer. As the fourth most common addictive substance in the world, 31 areca nut has been listed as Class I carcinogen by IARC. The habit of chewing areca nuts, which can cause oral precancerous lesions that may deteriorate into oral cancer, is prevalent in many Asia Pacific countries. 32 , 33 The risk of oral cancer increases with the increase of time and frequency of chewing areca nuts, regardless of the use of tobacco on top of it. 34 Since many people are becoming dependent on areca nuts and there has been no policy to restrict the use of areca nuts, it is critical for all countries to develop strategies regarding this addictive and harmful substance. 35 Moreover, a meta‐analysis suggested that there was a significant correlation between human papilloma virus and oral cancer. 36 Therefore, to avoid the harm caused by attributable risk factors, it is necessary for individuals to develop good living habits and improve their awareness of oral cancer prevention. As population growth and aging has become a more serious concern and specific risk factors has become more prevalent, the burden of cancer has become more alarming. 37 It is anticipated that, from 2020 to 2070, the number of patients with cancer worldwide will continue to rise, with the greatest increase being in low‐income countries. 38 As shown in the present study, the disease burden of oral cancer was negatively correlated with the level of SDI, indicating that in countries with low socioeconomic status, the disease burden of oral cancer is unproportional to the economic level. 39 Furthermore, the most serious burden of oral cancer caused by tobacco has been found in low‐and middle‐income countries. 40 This is closely related to the poor awareness of the attributable risk factors for oral cancer among people in these countries. 41 On the other hand, many low‐and middle‐income countries have difficulties in implementing the WHO Framework Convention on Tobacco Control, leading to failure to achieve goals of scheduled tobacco control. 42 Thus, the increasing prevalence of smoking will undoubtedly increase the burden of oral cancer in these countries. The present study also showed that the burden of oral cancer was gradually increasing in the younger population. A retrospective study revealed that the incidence of oral cancer in the younger population was on the rise, indicating that the etiology and clinical features of young patients might be unique. 43 Moreover, the burden of oral cancer among females showed an increasing trend in the present study, which might be partly related to the habits of tobacco and alcohol use among females. 44 Despite the strengths of the present study, limitations are inevitable. First, the data of lip cancer and oral cancer are not classified separately in the GBD database, which might have led to the overestimation of the incidence of oral cancer. Second, as the number of attributable risk factors of oral cancer is limited in the GBD database, the impact of other risk factors on oral cancer could not be quantitatively analyzed. In conclusion, oral cancer is still a prominent global public health problem due to the increasing disease burden. The burden of oral cancer in females and the younger population aged below 45 years has been on the rise; thus, attention should also be paid to them while concerning about the key population for oral cancer control. As there is a significant negative correlation between the burden of oral cancer and the SDI level, interventions against attributable risk factors need to be implemented based on the actual situations in different countries and regions. It is essential to improve the public awareness of primary oral cancer prevention and develop the economy, in order to control attributable risk factors and eventually reduce the oral cancer burden. AUTHOR CONTRIBUTIONS Rongyin Sun: Conceptualization (lead); methodology (lead); writing – original draft (lead); writing – review and editing (equal). Weijie Dou: Conceptualization (lead); methodology (lead); Writing – review and editing (equal). Weiliang Liu: Conceptualization (equal); methodology (equal); Writing – review and editing (equal). Jin Li: methodology (equal); writing – original draft (equal). Xiangxiang Han: methodology (equal); writing – original draft (equal). Shunhang Li: Formal analysis (lead); software (lead). Xueqian Wu: Data curation (equal). Fei Wang: Data curation (equal). Xin Xu: Conceptualization (lead); supervision (equal); writing – review and editing (lead). Jing Li: Conceptualization (lead); supervision (equal); writing – review and editing (lead). Supporting information Figure S1. Click here for additional data file. Figure S2. Click here for additional data file. Figure S3. Click here for additional data file. Figure S4. Click here for additional data file. Table S1. Table S2. Table S3. Table S4. Table S5. Click here for additional data file. ACKNOWLEDGMENTS The authors are grateful to the collaborators of the Global Burden of Disease study 2019 for their work. We also appreciate the support from the following funding: Shandong traditional Chinese medicine science and technology project (grant number No. M‐2022235); Weifang Medical Science and technology development plan project (grant number No. 2021YX047); High‐quality professional degree teaching case base project of Shandong Province (grant number SDYAL2022149); Student Innovation and Entrepreneurship Training Plan of Weifang Medical University (grant number X2022242); and Public Domestic Visiting Program of Weifang Medical University (grant number 20237‐10). DATA AVAILABILITY STATEMENT The datasets analyzed for this study can be found in the Global Burden of Disease database [http://ghdx.healthdata.org/gbd‐results‐tool]. ==== Refs REFERENCES 1 Sarode G , Maniyar N , Sarode SC , Jafer M , Patil S , Awan KH . Epidemiologic aspects of oral cancer. Dis Mon. 2020;66 (12 ):100988. doi:10.1016/j.disamonth.2020.100988 32605720 2 Ferlay J , Colombet M , Soerjomataram I , et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144 (8 ):1941‐1953. doi:10.1002/ijc.31937 30350310 3 Sung H , Ferlay J , Siegel RL , et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71 (3 ):209‐249. doi:10.3322/caac.21660 33538338 4 Valdez JA , Brennan MT . Impact of oral cancer on quality of life. Dent Clin N Am. 2018;62 (1 ):143‐154. doi:10.1016/j.cden.2017.09.001 29126491 5 Krishna Rao SV , Mejia G , Roberts‐Thomson K , et al. Epidemiology of oral cancer in Asia in the past decade–an update (2000–2012). Asian Pac J Cancer Prev. 2013;14 (10 ):5567‐5577. doi:10.7314/apjcp.2013.14.10.5567 24289546 6 Borse V , Konwar AN , Buragohain P . Oral cancer diagnosis and perspectives in India. Sens Int. 2020;1 :100046. doi:10.1016/j.sintl.2020.100046 34766046 7 Yang Y , Zhou M , Zeng X , Wang C . The burden of oral cancer in China, 1990‐2017: an analysis for the global burden of disease, injuries, and risk factors study 2017. BMC Oral Health. 2021;21 (1 ):44. doi:10.1186/s12903-020-01386-y 33509185 8 Conway DI , Petticrew M , Marlborough H , Berthiller J , Hashibe M , Macpherson LMD . Socioeconomic inequalities and oral cancer risk: a systematic review and meta‐analysis of case‐control studies. Int J Cancer. 2008;122 (12 ):2811‐2819. doi:10.1002/ijc.23430 18351646 9 American Cancer Society . Cancer Facts & Figures. 2019 Accessed August 20, 2022. https://www.cancer.org/research/cancer‐facts‐statistics/all‐cancer‐facts‐figures/cancer‐facts‐figures‐2019.html 10 Ren ZH , Hu CY , He HR , Li YJ , Lyu J . Global and regional burdens of oral cancer from 1990 to 2017: results from the global burden of disease study. Cancer Commun (Lond). 2020;40 (2‐3 ):81‐92. doi:10.1002/cac2.12009 32067418 11 Du M , Nair R , Jamieson L , et al. Incidence trends of lip, oral cavity, and pharyngeal cancers: global burden of disease 1990–2017. J Dent Res. 2020;99 (2 ):143‐151. doi:10.1177/0022034519894963 31874128 12 Zhu S , Zhang F , Zhao G , et al. Trends in the global burden of oral cancer joint with attributable risk factors: results from the global burden of disease study 2019. Oral Oncol. 2022;134 :106189. doi:10.1016/j.oraloncology.2022.106189 36208599 13 GBD 2019 Diseases and Injuries Collaborators . Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396 (10258 ):1204‐1222. doi:10.1016/S0140-6736(20)30925-9 33069326 14 GBD 2019 Risk Factors Collaborators . Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396 (10258 ):1223‐1249. doi:10.1016/S0140-6736(20)30752-2 33069327 15 Kassebaum NJ , Arora M , Barber RM , et al. Global, regional, and national disability‐adjusted life‐years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990‐2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388 (10053 ):1603‐1658. doi:10.1016/S0140-6736(16)31460-X 27733283 16 GBD 2017 Oesophageal Cancer Collaborators . The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol Hepatol. 2020;5 (6 ):582‐597. doi:10.1016/S2468-1253(20)30007-8 32246941 17 Zi H , He SH , Leng XY , et al. Global, regional, and national burden of kidney, bladder, and prostate cancers and their attributable risk factors, 1990–2019. Mil Med Res. 2021;8 (1 ):60. doi:10.1186/s40779-021-00354-z 34819142 18 Liu Q , He H , Yang J , Feng X , Zhao F , Lyu J . Changes in the global burden of depression from 1990 to 2017: findings from the global burden of disease study. J Psychiatr Res. 2020;126 :134‐140. doi:10.1016/j.jpsychires.2019.08.002 31439359 19 Hankey BF , Ries LA , Kosary CL , et al. Partitioning linear trends in age‐adjusted rates. Cancer Causes Control. 2000;11 (1 ):31‐35. doi:10.1023/a:1008953201688 10680727 20 Warnakulasuriya S , Kerr AR . Oral cancer screening: past, present, and future. J Dent Res. 2021;100 (12 ):1313‐1320. doi:10.1177/00220345211014795 34036828 21 Kaur J , Jacobs R , Huang Y , Salvo N , Politis C . Salivary biomarkers for oral cancer and pre‐cancer screening: a review. Clin Oral Investig. 2018;22 (2 ):633‐640. doi:10.1007/s00784-018-2337-x 22 Montero PH , Patel SG . Cancer of the oral cavity. Surg Oncol Clin N Am. 2015;24 (3 ):491‐508. doi:10.1016/j.soc.2015.03.006 25979396 23 Cheraghlou S , Schettino A , Zogg CK , Judson BL . Changing prognosis of oral cancer: an analysis of survival and treatment between 1973 and 2014. Laryngoscope. 2018;128 (12 ):2762‐2769. doi:10.1002/lary.27315 30194691 24 Miranda‐Filho A , Bray F . Global patterns and trends in cancers of the lip, tongue and mouth. Oral Oncol. 2020;102 :104551. doi:10.1016/j.oraloncology.2019.104551 31986342 25 Niaz K , Maqbool F , Khan F , Bahadar H , Ismail Hassan F , Abdollahi M . Smokeless tobacco (paan and gutkha) consumption, prevalence, and contribution to oral cancer. Epidemiol Health. 2017;39 :e2017009. doi:10.4178/epih.e2017009 28292008 26 Rafique I , Nadeem Saqib MA , Bashir F , et al. Comparison of tobacco consumption among adults in SAARC countries (Pakistan, India and Bangladesh). J Pak Med Assoc. 2018;68 ((Suppl 2)(5) ):S2‐S6. 27 Khan Z , Khan S , Christianson L , Rehman S , Ekwunife O , Samkange‐Zeeb F . Smokeless tobacco and oral potentially malignant disorders in South Asia: a protocol for a systematic review. Syst Rev. 2016;5 (1 ):142. doi:10.1186/s13643-016-0320-7 27558171 28 Yan J , Xie L , Shen G , et al. GSTM1 polymorphism, smoking, alcohol drinking and oral cancer susceptibility in Asians: a meta‐analysis. J Pract Stomatol. 2014;30 (04 ):515‐521. 29 Maasland DH , van den Brandt PA , Kremer B , et al. Alcohol consumption, cigarette smoking and the risk of subtypes of head‐neck cancer: results from The Netherlands Cohort Study. BMC Cancer. 2014;14 :187. doi:10.1186/1471-2407-14-187 24629046 30 Hashibe M , Li Q , Chen CJ , et al. Involuntary smoking and the risk of head and neck cancer in an east Asian population. Cancer Epidemiol. 2019;59 :173‐177. doi:10.1016/j.canep.2019.01.020 30785070 31 Gupta PC , Ray CS , Papke RL , et al. Perspectives on areca nut with some global implications: symposium report. Transl Res Oral Oncol. 2018;3 :2057178X18814068. doi:10.1177/2057178X18814068 32 Gunjal S , Pateel DGS , Yang YH , et al. An overview on betel quid and areca nut practice and control in selected Asian and South East Asian countries. Subst Use Misuse. 2020;55 (9 ):1533‐1544. doi:10.1080/10826084.2019.1657149 32569533 33 Warnakulasuriya S , Chen THH . Areca nut and oral cancer: evidence from studies conducted in humans. J Dent Res. 2022;101 (10 ):1139‐1146. doi:10.1177/00220345221092751 35459408 34 Guha N , Warnakulasuriya S , Vlaanderen J , Straif K . Betel quid chewing and the risk of oral and oropharyngeal cancers: a meta‐analysis with implications for cancer control. Int J Cancer. 2014;135 (6 ):1433‐1443. doi:10.1002/ijc.28643 24302487 35 Mehrtash H , Duncan K , Parascandola M , et al. Defining a global research and policy agenda for betel quid and areca nut. Lancet Oncol. 2017;18 (12 ):e767‐e775. doi:10.1016/S1470-2045(17)30460-6 29208442 36 Chaitanya NC , Allam NS , Gandhi Babu DB , et al. Systematic meta‐analysis on association of human papilloma virus and oral cancer. J Cancer Res Ther. 2016;12 (2 ):969‐974. doi:10.4103/0973-1482.179098 27461683 37 Torre LA , Bray F , Siegel RL , Ferlay J , Lortet‐Tieulent J , Jemal A . Global cancer statistics, 2012. CA Cancer J Clin. 2015;65 (2 ):87‐108. doi:10.3322/caac.21262 25651787 38 Soerjomataram I , Bray F . Planning for tomorrow: global cancer incidence and the role of prevention 2020‐2070. Nat Rev Clin Oncol. 2021;18 (10 ):663‐672. doi:10.1038/s41571-021-00514-z 34079102 39 Harris JA , Ritchie CA , Hanna GJ , McCain JP , Ji YD . The inequitable global burden of lip and oral cancers: widening disparities across countries. J Oral Maxillofac Surg. 2021;79 (6 ):1364‐1372. doi:10.1016/j.joms.2020.12.035 33497647 40 Chaturvedi P , Singh A , Chien CY , Warnakulasuriya S . Tobacco related oral cancer. BMJ. 2019;365 :l2142. doi:10.1136/bmj.l2142 31167798 41 Gupta N , Gupta R , Acharya AK , et al. Changing trends in oral cancer—a global scenario. Nepal J Epidemiol. 2016;6 (4 ):613‐619. doi:10.3126/nje.v6i4.17255 28804673 42 Bilano V , Gilmour S , Moffiet T , et al. Global trends and projections for tobacco use, 1990‐2025: an analysis of smoking indicators from the WHO Comprehensive Information Systems for Tobacco Control. Lancet. 2015;385 (9972 ):966‐976. doi:10.1016/S0140-6736(15)60264-1 25784347 43 Hussein AA , Helder MN , de Visscher JG , et al. Global incidence of oral and oropharynx cancer in patients younger than 45 years versus older patients: a systematic review. Eur J Cancer. 2017;82 :115‐127. doi:10.1016/j.ejca.2017.05.026 28654785 44 Kruse AL , Bredell M , Grätz KW . Oral cancer in men and women: are there differences? Oral Maxillofac Surg. 2011;15 (1 ):51‐55. doi:10.1007/s10006-010-0253-6 21052752